In the current uncertain financial climate, with rising costs and tightening budgets, it is becoming more important than ever to minimize needless spending in clinical trials. Each day that a trial is carried out, sponsors incur enormous direct costs as well as significant expenses associated with lost sales opportunities. Further, with many top seller drugs coming off patent in the near future, increased competition from cheaper generics will add to the financial pressures that pharma companies continue to face. Although many costs are required to ensure safe and effective clinical trials, great potential exists for cutting unnecessary expenses while
maintaining, or even increasing, quality. While costs are on everyone's minds, many sponsors lack the practical tools to effectively decrease spending.

ExL Pharma's Clinical Cost Containment conference provides concrete information and strategies for reducing expenses while still achieving sound, high quality and meaningful clinical trials. Case studies and best practices allow conference participants to learn what other leading and successful companies are doing to minimize costs. Attendees will leave this conference with essential knowledge and skills to apply to their own divisions and take steps, both large and small, to maximize cost effectiveness when planning and executing clinical trials.